Full-Time

Head – Enterprise AI

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

In Person

Category
Engineering Management (1)
Required Skills
LLM
Microsoft Azure
Python
Data Science
Tensorflow
R
Neural Networks
Pytorch
Apache Spark
Machine Learning
Data Engineering
RAG
AWS
DevOps
Google Cloud Platform
Requirements
  • 15+ years of experience in data science, machine learning, or a related field, with a proven track record of delivering impactful production systems with at least 10 years in a leadership role
  • Deep expertise across the full spectrum of AI technologies, including classical Machine Learning, Deep Learning, and advanced Generative AI/Large Language Model architectures (e.g., Retrieval-Augmented Generation systems, fine-tuning)
  • Proven ability to define and implement enterprise-grade MLOps frameworks, including automated model CI/CD pipelines, feature stores, model registries, and production monitoring/drift detection
  • Hands-on architectural experience with major cloud platforms (AWS, GCP, or Azure), specifically around managed data science services and scalable data pipelines (e.g., Spark, cloud data warehousing solutions)
  • Expert-level proficiency in programming languages such as Python or R and extensive experience with ML libraries such as TensorFlow, Vertex AI, PyTorch, etc.
  • A strong background in data engineering with development experience in building data products/services in a cloud-based data platforms will be highly desirable
  • Demonstrated ability to define a future-state technology roadmap that balances technical debt reduction with cutting-edge innovation in the AI space
  • Proven track record of leading multiple AI/ML programs from initiation through development and deployment with quantified success metrics
  • Demonstrated ability to translate business challenges into actionable AI strategies and roadmaps
  • Exceptional communication and presentation skills, with the ability to convey complex technical concepts to both technical and non-technical audiences
  • Exceptional people leader with strong leadership and team-building skills, with a passion for mentoring and growing data science talent and fostering of continuous culture of innovation
  • Deeply passionate about creating a team culture with a strong emphasis on execution, customer advocacy, cross-functional collaboration, and a fun working and knowledge sharing environment
  • A bachelor's, master's, or Ph.D in Computer Science, Statistics, Data Science, Applied Math, Engineering, or a related field
Responsibilities
  • Develop AI Strategy: Help define and articulate a comprehensive enterprise AI strategy that aligns with business objectives and provides a unified approach to AI development and deployment
  • Team Leadership: Lead, mentor, and grow a team of high-performing AI practitioners (data scientists, ML engineers, statisticians) responsible for building and deploying production-ready AI solutions
  • Demand Prioritization: Working in partnership with the Enterprise AI Core Team to establish and manage a clear, repeatable process for prioritizing AI use cases from across the company, ensuring projects with the highest business value and strategic impact are selected
  • Build a Common Foundation: Architect and oversee the development of a unified AI platform and toolkit to serve as the foundation for all AI solutions, ensuring consistency, scalability, and efficiency
  • Stakeholder Management: Work in partnership with the portfolio management team to align with leaders from every business function to understand their needs, manage expectations, and evangelize the value of AI
  • Governance and Ethics: Work in partnership with the AI Governance team to enforce strong governance frameworks, including ethical AI principles and responsible use guidelines
  • Technology and Innovation: Stay abreast of the latest trends in Generative AI, machine learning, and data science, and lead the charge in adopting innovative technologies that create a competitive advantage
  • Deployment to Production: Guide the team in the end-to-end lifecycle of AI projects, from ideation and development to successful deployment, monitoring, and maintenance in a production environment. To accomplish this, partnering closely with the data engineering team in ensuring access to relevant, high-quality data
  • AI Literacy & Change Management: Drive the necessary organizational change by developing and implementing company-wide AI training and education programs to foster AI literacy, build internal capability, enable personal productivity, and ensure responsible, informed adoption of AI tools across all business functions in driving organizational effectiveness and efficiency
Desired Qualifications
  • Data Engineering background will be highly desirable
  • (None other listed)

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Simplify Jobs

Simplify's Take

What believers are saying

  • Bariatric surgery market expansion as da Vinci outperforms GLP-1 drugs for sustained weight loss.
  • Ion bronchoscopy system procedures grew 39% YoY with 1,041 installed units capturing lung cancer detection.
  • Less than 5% of eligible surgeries globally performed robotically indicates substantial international adoption runway.

What critics are saying

  • FDA Class II recalls of instruments with fraying cables disrupt 86% of Q1 recurring revenue.
  • FDA safety communication on curved tip staplers halts hospital use, eroding surgeon confidence in reliability.
  • EU MDR recertification deadline December 2028 halts 25% European sales during redesign and testing.

What makes Intuitive Surgical unique

  • 70-80% market share in soft-tissue robotics with 11,395 installed da Vinci systems globally.
  • 85% recurring revenue from instruments, accessories, and service contracts provides predictable cash flow.
  • da Vinci 5 platform expands into cardiac surgery and complex procedures previously requiring open surgery.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Intuitive Surgical who can refer or advise you

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Apr 7th, 2026
Intuitive Surgical emerges as dark horse in anti-obesity market as surgery outperforms GLP-1 drugs

Intuitive Surgical could emerge as a dark horse in the anti-obesity market as bariatric surgery proves more effective than GLP-1 drugs for long-term weight loss. A recent study of over 50,000 patients found surgery patients lost an average of 58 pounds after two years, compared to just 12 pounds for those using GLP-1 medications. The study also showed surgery delivers more sustainable results. Gastric bypass patients maintain around 52% of their excess weight loss after 10 years, whilst GLP-1 users often regain all lost weight after stopping treatment. Intuitive's da Vinci surgical system offers minimally invasive bariatric surgery options. The company generated $10.1 billion in revenue last year, up from $8.4 billion, with profit margins around 28%. Despite shares falling over 20% this year, the company's position in surgical innovation makes it a compelling long-term investment.

Yahoo Finance
Mar 29th, 2026
Intuitive Surgical shares drop 19% YTD, but analysts see 15% upside potential

Intuitive Surgical has experienced recent share price weakness, declining 3% in one day with negative returns over the past week, month and three months. The stock currently trades at $452.66, down 10.1% over one month and 19.45% year-to-date, though three-year total shareholder returns remain strong at 77.19%. The medical technology company reports annual revenue of $10.1 billion and net income of $2.9 billion, maintaining a dominant position in minimally invasive surgical technology. According to one valuation analysis, Intuitive Surgical's fair value sits at $532.46, suggesting the stock is undervalued by approximately 15% at current levels. The analysis projects 12% annual revenue growth over the next five years, supported by recurring revenues from spare parts and software licences, with profit margins expected to reach 30% from the current 28.6%.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical shares up 23% after Jim Cramer's buy recommendation

Intuitive Surgical shares rose 23% following Jim Cramer's recommendation on CNBC's Squawk on the Street in June 2025, where he urged investors to "just go buy ISRG". The medical robotics company experienced a 27% surge in October after reporting third-quarter earnings that beat analyst estimates. Revenue reached $2.51 billion against expectations of $2.40 billion, whilst adjusted earnings per share hit $2.40 versus the predicted $1.98. However, the stock declined 2.7% in January 2026 after Intuitive Surgical released preliminary fourth-quarter results, citing concerns that Medicaid funding cuts and competing products could slow growth of its robotic surgical systems. Despite the recent setback, shares remain up significantly since Cramer's initial endorsement, though they're down 7.8% over the past year.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical faces tariff headwinds and rising competition despite 19% revenue growth to $2.87B

Intuitive Surgical faces headwinds from tariffs and increased competition in the robotic-assisted surgery market, yet its fundamentals remain strong. The medical device company reported fourth-quarter revenue growth of 19% to $2.87 billion, whilst adjusted earnings per share rose 14.5% to $2.53. Procedures using its da Vinci surgical system increased 17%, with the installed base growing 12% to 11,106 units. However, the stock trades at 47.6 times forward earnings, compared to the healthcare sector average of 17.1. New competition is emerging, with Medtronic's Hugo system recently cleared and Johnson & Johnson expected to launch its own device soon. Despite these challenges, Intuitive Surgical maintains advantages through switching costs and extensive real-world data, whilst the underpenetrated robotic-assisted surgery market offers long-term growth potential.

Yahoo Finance
Mar 24th, 2026
ISRG maintains 37% operating margins in Q4 despite 95 bps tariff drag

Intuitive Surgical maintained a 37% operating margin in Q4 despite tariffs creating a 95 basis point drag, alongside higher facility costs and unfavourable product mix from newer platforms like da Vinci 5 and Ion. The company offset these pressures through product cost reductions, component savings and manufacturing efficiencies. Procedure growth of 18% in Q4 and recurring revenue now comprising 81% of total revenues provided operating leverage. Management's 2026 gross margin guidance of 67-68% suggests continued stability, even as tariff headwinds are expected to increase to roughly 1.2% of revenues. Meanwhile, Boston Scientific expanded adjusted operating margins by 100 basis points to 28% in 2025, though tariffs will offset favourable product mix in 2026. The company expects 50-75 basis points operating margin expansion in 2026 through scale efficiencies and supply-chain optimisation.